Naprilene (Enalapril Maleate)

Enalapril, the active ingredient in Naprilene, is an ACE inhibitor presented as an oral tablet for oral use. It is used to lower elevated blood pressure and to manage heart failure, including after myocardial infarction, in adult patients. GNH USA supplies Naprilene as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naprilene, an ACE inhibitor, is employed in several cardiovascular conditions where the renin‑angiotensin system contributes to disease progression.

Hypertension: lowers systolic and diastolic pressure, reducing risk of stroke and heart attack. Heart failure: improves symptoms and survival by decreasing afterload. Asymptomatic left ventricular dysfunction: slows progression to overt heart failure. Post‑myocardial infarction: reduces mortality and reinfarction rates.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Cough: dry, persistent throat irritation. - Dizziness or light‑headedness, especially after the first dose. - Headache: mild to moderate intensity. - Fatigue: general feeling of tiredness. - Hypotension: especially in volume‑depleted patients.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips, tongue, or airway. - Hyperkalemia: elevated serum potassium levels. - Acute renal impairment: sudden decrease in kidney function. - Neutropenia or agranulocytosis: marked reduction in white blood cells. - Hepatic dysfunction: abnormal liver enzyme elevations.

Before initiating therapy, clinicians should assess relevant clinical factors and monitor patients during treatment.

Monitor blood pressure: check regularly to avoid excessive hypotension. Assess renal function: obtain baseline creatinine and repeat as needed. Check serum potassium: especially when combined with potassium‑sparing agents. Avoid use in pregnancy: contraindicated due to fetal toxicity (Category D). Use caution in aortic stenosis: may precipitate severe hypotension. Store at below 25°C: keep in the original pack, protect from moisture.

Enalapril may interact with several drug classes, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Aliskiren (in diabetic patients): heightened risk of hypotension and renal dysfunction. - Potassium‑sparing diuretics (e.g., spironolactone): may cause dangerous hyperkalemia. - High‑dose NSAIDs: can blunt antihypertensive effect and impair renal function.

Moderate Interactions (Monitor Closely): - Thiazide diuretics: additive blood‑pressure lowering effect. - Lithium: increased lithium concentrations, risk of toxicity. - Concurrent ACE inhibitors or ARBs: additive renin‑angiotensin blockade, avoid combined use.